Profile

Cover photo
5,341 followers|1,644,727 views
AboutPostsPhotosYouTube

Stream

MAPS

Shared publicly  - 
 
The Center of the Cyclone is an autobiography by John C. Lilly, Ph.D., detailing his scientific exploration of LSD, isolation tanks, and human consciousness. The new 45th Anniversary edition is now available on +Amazon.com. amzn.to/2jWhj3h
3
1
T Something's profile photo
 
a must read, quite interesting
Add a comment...

MAPS

Shared publicly  - 
 
Last month, the U.S. Food and Drug Administration encouraged MAPS to apply for Breakthrough Therapy Designation for MDMA-assisted psychotherapy as a treatment for posttraumatic stress disorder (PTSD). According to the FDA, a breakthrough therapy is intended "to treat a serious or life threatening disease condition," and "may demonstrate substantial improvement over existing therapies." If approved, Breakthrough Therapy Designation could expedite the development and review of MDMA-assisted psychotherapy for PTSD.
2017: Together, We’re Making Medicines Psychedelic Science 2017 will feature 175+ presenters over six days January 12, 2017 Happy 2017 from the Multidisciplinary Association for Psychedelic Studies (MAPS) ! Last month, the U.S. Food and Drug...
5
3
Add a comment...

MAPS

Shared publicly  - 
 
Ketamine: A Transformational Catalyst

Michael Ziegler publishes a review of The Ketamine Papers: Science, Therapy, and Transformation, the new MAPS-published book edited by Phil Wolfson, M.D., and Glenn Hartelius, Ph.D. http://bit.ly/2j2dJFN
3
1
Add a comment...

MAPS

Shared publicly  - 
 
Happy birthday to the late Albert Hofmann, the pioneering chemist who first synthesized LSD and psilocybin. Today, we honor Hofmann's monumental contributions to the field of psychedelic science.
9
1
Add a comment...

MAPS

Shared publicly  - 
 
Bringing MDMA-Assisted Psychotherapy to Brazil

At Psychedelic Science 2017, Principal Investigator Eduardo E. Schenberg, Ph.D., will speak about the process of initiating psychedelic research in Brazil. http://bit.ly/2iZ1I3V

3
Add a comment...

MAPS

Shared publicly  - 
 
Salvinorin-A: A Perception-Modifying Drug with a Unique Neurophysiological Profile

Salvinorin-A (SA) is a potent perception-modifying drug found in the leaves of the plant Salvia divinorum. At Psychedelic Science 2017, Jordi Riba, Ph.D., will present findings from research investigating the human pharmacology of salvinorin-A conducted. http://bit.ly/2iWUdfW
6
3
Add a comment...

Communities

MAPS

Shared publicly  - 
 
+Berkeley Wellness explores psychedelic research investigating psychedelic-assisted psychotherapy as a treatment for depression and PTSD.
1
1
Add a comment...

MAPS

Shared publicly  - 
 
Psilocybin Research: Therapist Competencies and Therapeutic Processes

Bill Richards, S.T.M., Ph.D., and Jeffrey Guss, M.D., will host a full-day workshop about psilocybin at Psychedelic Science 2017, featuring an exploration of the therapeutic orientations and practical techniques that appear to enhance the probability of safety and efficacy in clinical research studies with psilocybin. http://bit.ly/2jOoSx9
4
Jesus “H” Christ's profile photo
 
I'll take one bottle, please 
Add a comment...

MAPS

Shared publicly  - 
 
MDMA Vs. Ecstasy: How They Differ, Risks, And Benefits You Need to Know

+Medical Daily explores the pharmacological differences between MDMA and “Ecstasy,” highlighting how misrepresentation of MDMA in media affects cultural perception. http://bit.ly/2hFJ1QW
4
Add a comment...

MAPS

Shared publicly  - 
 
+The Mercury News interviews novelist +Ayelet Waldman about her experience microdosing LSD to treat symptoms of depression. 
In her latest book, Berkeley author Ayelet Waldman recounts her one-month experiment taking small doses of LSD to overcome suicidal depression.
7
5
Add a comment...

MAPS

Shared publicly  - 
 
Comedian +Shane Mauss interviews Allison Wilens of MAPS Public Benefit Corporation (MPBC) about the process of developing clinical trials of MDMA-assisted psychotherapy as a treatment for multiple mental health issues. 
Join Comedian Shane Mauss as he interviews science experts across the country in a journey to find out what makes us who we are.
3
Add a comment...

MAPS

Shared publicly  - 
 
Hand in Hand: How Psychedelic Harm Reduction Is Making a Difference Now

“The Multidisciplinary Association for Psychedelic Studies (MAPS) continues to make huge strides towards the goal of establishing psychedelics as legal medicines. In advancing the cause of psychedelic therapy, the organization has also become a repository for experience and techniques essential for assisting people journeying through difficult psychedelic experiences.” —Shannon Clare Petitt, M.A. bit.ly/2ixvcES
4
Add a comment...
Communities
Contact Information
Contact info
Phone
831-429-MDMA (6362)
Email
Address
1115 Mission Street, Santa Cruz, CA 95062
Story
Tagline
Supporting psychedelic and medical marijuana research since 1986
Introduction
Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization. MAPS functions as a non-profit pharmaceutical company working to make psychedelics and medical marijuana available to patients, physicians, and therapists on a legal, prescription, generic basis for public health benefits and health care cost savings.